MassChallenge

MassChallenge is a global startup accelerator supporting early-stage entrepreneurs across various industries. Founded in 2009, it provides mentorship, resources, and networking opportunities through its programs worldwide.

Cait Brumme

Acting CEO

Nick Dougherty

Managing Director, MassChallenge HealthTech

Siobhan Dullea

CEO

Matthew Lashmar

Managing Director

Camila Lecaros

Managing Director

Yonit Serkin

Managing Director

Devon Sherman

Founding Director, Head of MassChallenge FinTech

Michelle Williams

Vice President and Head of Texas Strategy

Past deals in Zurich

VAY

Non Equity Assistance in 2021
VAY is a Zurich-based computer vision company that specializes in human motion analysis, utilizing advanced technology to digitize human movements through a simple camera. Founded in 2019, VAY develops innovative solutions that make products smarter, more interactive, and immersive by leveraging real-life data and feedback. Their platform employs artificial intelligence to accurately perceive and predict human motion, facilitating seamless interaction between digital systems and users. The company's hardware and system agnostic approach allows for versatile applications across various sectors, including health, sports, and gaming, providing valuable insights for physiotherapy, rehabilitation, and gait or posture analysis.

Oxyle

Non Equity Assistance in 2021
Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.

Eaternity

Non Equity Assistance in 2021
Eaternity develops a software management platform for the restaurant industry that provides real-time calculations for allergen and nutrition declarations and estimates the carbon footprint of meals and restaurant operations. The platform also tracks supply-chain data and delivers insights to support smart decision-making toward a more sustainable food system. Through the Eaternity Score, the environmental impact of food products is made transparent to consumers and decision-makers. The company was founded in 2014 and is based in Zurich, Switzerland.

Synthara

Non Equity Assistance in 2020
Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.

Planted Foods

Grant in 2019
Planted Foods AG is a Swiss company founded in 2019, specializing in the development of plant-based meat alternatives. The company produces products such as planted chicken and BBQ planted chicken, utilizing a formulation that includes pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. Planted Foods employs advanced technology to transform these natural ingredients into nutritious, high-protein meat substitutes that appeal to consumers seeking plant-based options. In addition to its product offerings, the company operates an e-commerce platform to facilitate direct sales to customers. Headquartered in Zürich, Switzerland, Planted Foods is committed to providing delicious and sustainable meat alternatives.

PXL Vision

Grant in 2019
PXL Vision is a Swiss identity verification software provider focused on automated, AI-based onboarding and fraud prevention. Its cross-platform Daego solution creates trusted digital identities for customer onboarding by verifying identity documents and performing liveness checks through computer vision and machine learning. Founded in 2017 and headquartered in Zurich, the company operates research and development centers in Novi Sad and Yerevan to advance high-performance ML-based verification. PXL Vision serves industries such as insurance, gambling, fintech, banking and healthcare with a modular, configurable system that supports fully automated identity verification, reduces dropout, improves onboarding conversion, and helps businesses comply with regulatory requirements while protecting customer data. The company emphasizes reliable verifications and safe digital interactions by leveraging proprietary machine learning to confirm document authenticity and user identity.

CellSpring

Grant in 2019
CellSpring is a biotechnology company based in Zurich, Switzerland, that develops 3D tissue models for biological research. Its core offering, the 3D Bloom platform, enables rapid creation of biomimetic microtissues independent of cell type, supporting in vitro studies and drug development. The platform emphasizes speed, reliability, versatility, and ease of use, improving the fabrication of 3D cell cultures for diverse experimental applications.

Dimpora

Non Equity Assistance in 2019
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.

Microcaps

Non Equity Assistance in 2019
Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.

OxyPrem

Non Equity Assistance in 2019
OxyPrem AG is a Swiss company that specializes in the development, design, and manufacturing of advanced sensor solutions specifically for monitoring preterm infants. Established in 2018 and headquartered in Zurich, the company offers a reusable device that continuously measures hemoglobin oxygen saturation in the brains of high-risk preterm infants. By utilizing harmless near-infrared light technology, OxyPrem provides real-time monitoring, which significantly enhances the clinical care provided to this vulnerable patient group. The innovations from OxyPrem aim to prevent early death and severe long-term brain damage, thereby minimizing the risk of disabilities and other complications associated with premature birth.

Rapid Graft

Non Equity Assistance in 2018
Rapid Graft, established in 2018 and based in Zurich, Switzerland, specializes in developing innovative medical devices for precise skin graft harvesting. Their flagship product is a novel dermatome designed to efficiently obtain small split-skin grafts, aiming to enhance chronic wound treatment and facilitate future tissue engineering needs. The company's device enables surgeons to perform skin grafting procedures more effectively, minimizing the risk of infection, scarring, and requiring fewer specialized interventions or operating room resources.

Parquery

Non Equity Assistance in 2018
Founded in 2014, Parquery develops a web application that provides real-time on-street parking availability data using computer vision and machine learning. It offers smart routing options to users and enables parking managers to monitor usage patterns.

Sleepiz

Non Equity Assistance in 2017
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.

Versantis

Series A in 2017
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

Versantis

Non Equity Assistance in 2016
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

Smart Home Technology

Grant in 2016
Smart Home Technology GmbH, founded in 2014 and based in Zurich, Switzerland, specializes in the development of smart devices and home automation products. The company is dedicated to enhancing existing systems by providing ultra-low power, reliable, and cost-effective solutions derived from scientific research and advanced technological expertise. Smart Home Technology employs zero-standby power technology, enabling the operation of electrical devices and household appliances with no standby energy losses. By focusing on security and communication concepts, the company offers highly efficient systems integrated with smart software, catering primarily to business customers in the cleantech and smart home sectors.

Rqmicro

Non Equity Assistance in 2016
Rqmicro is a Swiss company based in Zurich, founded in 2013, that specializes in pathogen separation and detection technology. The company has developed proprietary reagents and instruments for rapid microbiological testing, which provide accurate results in under one hour. Rqmicro's technology is utilized for the rapid assessment of water and food safety, enabling clients to detect dangerous pathogens effectively. By delivering quantitative data on contamination, Rqmicro's solutions enhance the overall safety of water and food products, addressing critical public health concerns.

Pingen

Grant in 2015
Pingen is an online solution to send documents by letter post for private, business, and software integration. Users can either upload PDFs from their desktops or fetch files online from their Dropbox, Google Drive, and Microsoft Skydrive accounts. Pingen was launched in 2010 and is operated from Zürich, Switzerland.

MagnebotiX

Grant in 2015
MagnebotiX, founded in 2014 and based in Zurich, specializes in the development and production of advanced magnetic manipulation systems. The company focuses on creating magnetic field generators and micromagnetic agents, utilizing their extensive expertise in the field. Their innovative products are designed to facilitate both fundamental and applied scientific research, enabling users to perform complex micromanipulation tasks wirelessly. MagnebotiX’s systems are particularly valuable as untethered mechanical probes, allowing access to otherwise unreachable areas and enabling targeted cargo delivery for minimally invasive biological studies. By leveraging the transmission of power and guidance through applied magnetic fields, MagnebotiX supports a wide range of research applications in the field of magnetic phenomena and magnetic microrobots.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.